Light magnesium carbonate, oxetacaine (Mucaine)
Light magnesium carbonate, oxetacaine
Adcock ingram limited
Every registration of this product has been cancelled.
Registration
- Applicant
- Adcock ingram limited
- Registrations
- 1
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Mucaine tablet TABLET LIGHT MAGNESIUM CARBONATE 83,8 MG OXETACAINE 5 MG | Tablet | E1224E/11.4.3/1224 | Cancelled | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
Listings for this ingredient that could not be applied to this product
S4: Oxetacaine
- when intended for ophthalmic or parenteral use;
- except in oral preparations containing an antacid. (S1)
Consolidated Schedules 06 July 2026, lines 7429 to 7433
S1: Magnesium
- in oral preparations or mixtures containing more than 250 mg of Magnesium per recommended daily dose alone or in combination with other active pharmaceutical ingredients. (S0)
Consolidated Schedules 06 July 2026, lines 815 to 816
S1: Oxetacaine
- in oral preparations containing an antacid;
- except when intended for ophthalmic or parenteral use. (S4)
Consolidated Schedules 06 July 2026, lines 943 to 947
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
Combination product
This product contains more than one active ingredient, so it has no single molecular structure.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.